Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tuhura Biosciences Inc. (KTRA:NASDAQ), powered by AI.
Tuhura Biosciences Inc. is currently trading at $2.14. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tuhura Biosciences Inc. on Alpha Lenz.
View Tuhura Biosciences Inc.'s valuation metrics on Alpha Lenz.
“Tuhura Biosciences Inc.'s ROE is -370.8%. Explore profitability and growth together.”
Ask for details →Tuhura Biosciences Inc. is a biotechnology company involved in discovering and developing innovative therapies to address unmet medical needs. The company's primary function is to enhance the quality of life for patients by focusing on cutting-edge research and leveraging advanced technologies in drug discovery and development. Tuhura Biosciences operates at the intersection of healthcare and technology, influencing the biotechnology and pharmaceutical industries. Its research initiatives are geared towards understanding complex biological systems and translating this knowledge into actionable medical interventions. By harnessing the power of data-driven insights and precision medicine, Tuhura Biosciences plays a significant role in the market, contributing to the advancement of personalized healthcare solutions and offering potential breakthroughs in the treatment landscape for various diseases. Its presence underscores the growing momentum in the biosciences sector, as companies strive to bring new therapies from the laboratory to the clinic, ultimately aiming to improve patient outcomes globally.
“Tuhura Biosciences Inc.'s ROE is -370.8%. Explore profitability and growth together.”
Ask for details →Tuhura Biosciences Inc. (ticker: KTRA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 1 employees.
The current price is $2.14 with a P/E ratio of -x and P/B of -x.
ROE is -370.77%.